# EDGAR Filing Document

**Accession Number:** 0001570562
**File Stem:** 0001570562-23-000040
**Filing Date:** 2023-3
**Character Count:** 18107
**Document Hash:** f6c1825978d2240dce1b825117213506
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001570562-23-000040.hdr.sgml**: 20230308

**ACCESSION NUMBER**: 0001570562-23-000040

**CONFORMED SUBMISSION TYPE**: S-8

**PUBLIC DOCUMENT COUNT**: 4

**FILED AS OF DATE**: 20230308

**DATE AS OF CHANGE**: 20230308

**EFFECTIVENESS DATE**: 20230308

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Evolus, Inc.
- **CENTRAL INDEX KEY:** 0001570562
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **IRS NUMBER:** 461385614
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** S-8
- **SEC ACT:** 1933 Act
- **SEC FILE NUMBER:** 333-270360
- **FILM NUMBER:** 23716676

**BUSINESS ADDRESS:**
- **STREET 1:** 520 NEWPORT CENTER DRIVE
- **STREET 2:** SUITE 1200
- **CITY:** NEWPORT BEACH
- **STATE:** CA
- **ZIP:** 92660
- **BUSINESS PHONE:** (949) 284-4555

**MAIL ADDRESS:**
- **STREET 1:** 520 NEWPORT CENTER DRIVE
- **STREET 2:** SUITE 1200
- **CITY:** NEWPORT BEACH
- **STATE:** CA
- **ZIP:** 92660

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **As filed with the Securities and Exchange Commission on March 8, 2023.**

**Registration No. 333-**

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**WASHINGTON, D.C. 20549**

___________________

**FORM S-8**

**REGISTRATION STATEMENT**

**UNDER**

**THE SECURITIES ACT OF 1933**

___________________

**Evolus, Inc.**

**(Exact name of registrant as specified in its charter)**

___________________

---

| | |
|:---|:---|
| **Delaware** | **46-1385614** |
| **(State or other jurisdiction of incorporation or organization)** | **(I.R.S. Employer Identification No.)** |

---

**520 Newport Center Drive, Suite 1200**

**Newport Beach, California 92660**

**(Address of Principal Executive Offices) (Zip Code)**

**Evolus, Inc. 2017 Omnibus Incentive Plan**

**(Full title of the plans)**

___________________

**David Moatazedi**

**President and Chief Executive Officer**

**Evolus, Inc.**

**520 Newport Center Drive, Suite 1200**

**Newport Beach, California 92660**

**(949) 284-4555**

**(Name and address of agent for service) (Telephone number, including area code, of agent for service)**

___________________

***Copies to*:**

---

| | |
|:---|:---|
| **Mark Peterson, Esq.<br>O'Melveny & Myers LLP<br>610 Newport Center Drive, Suite 1700<br>Newport Beach, California 92660<br> (949) 823-6900** | **Jeffrey J. Plumer<br>General Counsel<br>Evolus, Inc.<br>520 Newport Center Drive, Suite 1200<br> Newport Beach, California 92660<br>(949) 284-4555** |

---

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b–2 of the Exchange Act.

---

| | | | |
|:---|:---|:---|:---|
| Large accelerated filer | ☐ | Accelerated filer | ☐ |
| Non-accelerated filer | ☒ | Smaller reporting company | ☒ |
| | | Emerging growth company | ☒ |

---

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. ☒

------

**EXPLANATORY NOTE**

This Registration Statement is filed by the Registrant to register additional securities issuable pursuant to the Plan and consists of only those items required by General Instruction E to Form S-8.

**PART I**

**INFORMATION REQUIRED IN THE**

**SECTION 10(a) PROSPECTUS**

&nbsp;&nbsp;&nbsp;&nbsp;The document(s) containing the information specified in Part I of Form S-8 will be sent or given to participants as specified by Securities Act Rule 428(b)(1).

**PART II**

**INCORPORATION BY REFERENCE OF CONTENTS OF**

**REGISTRATION STATEMENT ON FORM S-8**

**Item 3.**&nbsp;&nbsp;&nbsp;&nbsp;**Incorporation of Certain Documents by Reference**

The following documents of the Company filed with the Securities and Exchange Commission (the "Commission") are incorporated herein by reference:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;&nbsp;&nbsp;&nbsp;<u>[The Company's](https://www.sec.gov/ix?doc=/Archives/edgar/data/1570562/000157056223000038/eols-20221231.htm)[Annual Report on Form 10-K for its fiscal year ended December 31, 202](https://www.sec.gov/ix?doc=/Archives/edgar/data/1570562/000157056223000038/eols-20221231.htm)[2](https://www.sec.gov/ix?doc=/Archives/edgar/data/1570562/000157056223000038/eols-20221231.htm)</u>, filed with the Commission on March 8, 2023 (Commission File No. 001-38381);

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;&nbsp;&nbsp;&nbsp;<u>[The description of the Company's Common Stock contained in its Registration Statement on Form 8-A filed with the Commission on February 1, 2018](http://www.sec.gov/Archives/edgar/data/1570562/000162828018000860/evolusform8-a12b.htm)</u>, as modified by th<u>[e description of the Company's Common Stock contained in](https://www.sec.gov/Archives/edgar/data/1570562/000157056223000038/exhibit4312312210k.htm)[Exhibit 4.3](https://www.sec.gov/Archives/edgar/data/1570562/000157056223000038/exhibit4312312210k.htm)</u> to the Company's Annual Report on Form 10-K for its fiscal year ended December 31, 2022, filed with the Commission on March 8, 2023 (each, Commission File No. 001-38381), and any other amendment or report filed for the purpose of updating such description; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;&nbsp;&nbsp;&nbsp;The Company's Registration Statements on Form S-8 previously filed with the Commission on <u>[March 4, 2022 (File No. 33](http://www.sec.gov/Archives/edgar/data/1570562/000157056222000074/evoluss-82022.htm)[3-263325)](http://www.sec.gov/Archives/edgar/data/1570562/000157056222000074/evoluss-82022.htm)</u>, <u>[March 26, 2021 (File No. 333-254746](http://www.sec.gov/Archives/edgar/data/1570562/000157056221000104/evoluss-82021.htm)</u>), <u>[February 25, 2020 (File No. 333-236620)](http://www.sec.gov/Archives/edgar/data/1570562/000157056220000063/evoluss-82019evergreen.htm)</u>, <u>[January 10, 2019 (File No. 333-229184)](http://www.sec.gov/Archives/edgar/data/1570562/000157056219000006/evoluss-81.htm)</u>, and <u>[February 16, 2018 (File No. 333-223068)](http://www.sec.gov/Archives/edgar/data/1570562/000162828018001829/evoluss-8.htm)</u> relating to the Plan.

All documents subsequently filed by the Company pursuant to Sections 13(a), 13(c), 14 and 15(d) of the Exchange Act, prior to the filing of a post-effective amendment which indicates that all securities offered hereby have been sold or which deregisters all securities then remaining unsold, shall be deemed to be incorporated by reference into this Registration Statement and to be a part hereof from the date of filing of such documents; provided, however, that documents or information deemed to have been furnished and not filed in accordance with Commission rules shall not be deemed incorporated by reference into this Registration Statement. Any statement contained herein or in a document, all or a portion of which is incorporated or deemed to be incorporated by reference herein, shall be deemed to be modified or superseded for purposes of this Registration Statement to the extent that a statement contained herein or in any other subsequently filed document which also is or is deemed to be incorporated by reference herein modifies or supersedes such statement. Any such statement so modified or superseded shall not be deemed, except as so modified or amended, to constitute a part of this Registration Statement.

**Item 5.**&nbsp;&nbsp;&nbsp;&nbsp;**Interests of Named Experts and Counsel**

The validity of the issuance of securities registered hereby is passed on for the Company by Jeffrey J. Plumer. Mr. Plumer is General Counsel, of the Company and is compensated by the Company as an employee. Mr. Plumer holds 48,815 shares of Company common stock, 167,394 Company restricted stock units that are payable in an equivalent number of shares of Company common stock, and Company stock options to acquire up to an additional 346,747 shares of Company common stock. Mr. Plumer is eligible to receive additional stock awards by the Company under the Evolus, Inc. 2017 Omnibus Incentive Plan.

**Item 8.&nbsp;&nbsp;&nbsp;&nbsp;Exhibits.**

The following exhibits are filed herewith or incorporated by reference as part of this Registration Statement:

------

---

| | |
|:---|:---|
| **<u>Exhibit No.</u>** | **<u>Description</u>** |
| 4.1 | <u>[Amended and Restated Certificate of Incorporation (incorporated by reference to Exhibit 3.1 to the Registrant's Current Report on Form 8-K filed on February 12, 2018).](http://www.sec.gov/Archives/edgar/data/1570562/000162828018001474/exhibit318-k21218.htm)</u> |
| 4.2 | <u>[Amended and Restated Bylaws (incorporated by reference to Exhibit 3.2 to the Registrant's Current Report on Form 8-K filed on February 12, 2018).](http://www.sec.gov/Archives/edgar/data/1570562/000162828018001474/exhibit328-k21218.htm)</u> |
| 4.3 | <u>[Specimen certificate evidencing shares of common stock of the Registrant (incorporated by reference to Exhibit 4.1 to the Registrant's Registration Statement on Form S-1, as amended (File No. 333-222478)).](http://www.sec.gov/Archives/edgar/data/1570562/000162828018000572/exhibit41s-1a1.htm)</u> |
| 5\* | <u>[Opinion of Counsel (Legality of Shares)](s-82023exhibit5.htm)</u> |
| 23.1\* | <u>[Consent of independent registered public accounting firm.](s-82023exhibit231.htm)</u> |
| 23.2\* | <u>[Consent of Counsel (included as part of Exhibit 5).](s-82023exhibit5.htm)</u> |
| 24.1 | <u>[Power of Attorney (included on signature page hereto).](#iede2adc70e884af993dde9eda10a7971_31)</u> |
| 99.1 | <u>[2017 Omnibus Incentive Plan (incorporated by reference to Exhibit 10.6 to the Registrant's Registration Statement on Form S-1, as amended (File No. 333-222478)).](https://www.sec.gov/Archives/edgar/data/1570562/000157056218000008/exhibit106s-1.htm)</u> |
| 107\* | <u>[Filing fee table](feetables82023.htm)</u> |

---

\*&nbsp;&nbsp;&nbsp;&nbsp;Filed herewith

------

**SIGNATURES**

&nbsp;&nbsp;&nbsp;&nbsp;Pursuant to the requirements of the Securities Act of 1933, as amended, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Newport Beach, State of California, on March 8, 2023.

---

| | |
|:---|:---|
| **EVOLUS, INC.** | **EVOLUS, INC.** |
|  | /s/ David Moatazedi |
| By: | David Moatazedi |
|  | President and Chief Executive Officer |

---

&nbsp;&nbsp;&nbsp;&nbsp;KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints David Moatazedi and Sandra Beaver and each or either of them, as his or her true and lawful attorney-in-fact and agent, with full power of substitution and resubstitution, for him or her and in his or her name, place and stead, in any and all capacities, to sign any and all amendments to this Registration Statement on Form S-8, including any and all post-effective amendments and amendments thereto, and to file the same, with all exhibits thereto and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorney-in-fact and agent, full power and authority to do and perform each and every act and thing requisite and necessary to be done in connection therewith, as fully to all intents and purposes as he or she might or could do in person, hereby ratifying and confirming all that said attorney-in-fact and agent, or their or his or her substitutes or substitute, may lawfully do or cause to be done by virtue hereof.

&nbsp;&nbsp;&nbsp;&nbsp;Pursuant to the requirements of the Securities Act of 1933, as amended, this Registration Statement has been signed below by the following persons on behalf of the Registrant and in the capacities and on the dates indicated.

---

| | | |
|:---|:---|:---|
| **<u>Signature</u>** | **<u>Title</u>** | **<u>Date</u>** |
| /s/ David Moatazedi | President, Chief Executive Officer and<br>Member of the Board of Directors<br>(Principal Executive Officer) | March 8, 2023 |
| David Moatazedi | President, Chief Executive Officer and<br>Member of the Board of Directors<br>(Principal Executive Officer) | March 8, 2023 |
| /s/ Sandra Beaver | Chief Financial Officer<br>(Principal Financial and Accounting Officer) | March 8, 2023 |
| Sandra Beaver | Chief Financial Officer<br>(Principal Financial and Accounting Officer) | March 8, 2023 |
| /s/ Vikram Malik | Chairman of the Board of Directors | March 8, 2023 |
| Vikram Malik | Chairman of the Board of Directors | March 8, 2023 |
| /s/ Simone Blank | Director | March 8, 2023 |
| Simone Blank | Director | March 8, 2023 |
| /s/ Robert Hayman | Director | March 8, 2023 |
| Robert Hayman | Director | March 8, 2023 |
| /s/ David Gill | Director | March 8, 2023 |
| David Gill | Director | March 8, 2023 |

---

------

---

| | | |
|:---|:---|:---|
| /s/ Peter C. Farrell, Ph.D., AM. | Director | March 8, 2023 |
| Peter C. Farrell, Ph.D., AM. | Director | March 8, 2023 |
| /s/ Karah Parschauer | Director | March 8, 2023 |
| Karah Parschauer | Director | March 8, 2023 |
| /s/ Brady Stewart | Director | March 8, 2023 |
| Brady Stewart | Director | March 8, 2023 |

---

## Ex-Filing

**Exhibit 107**

**Calculation of Filing Fee Tables**

**Form S-8**

(Form Type**)**

**Evolus, Inc.**

(Exact Name of Registrant as Specified in its Charter)

**Table 1—Newly Registered Securities**

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| **Security type** | **Security Class Title** | **Fee Calculation Rule** | **Amount Registered**<sup>(1)</sup> | **Proposed Maximum Offering Price Per Share** | **Maximum Aggregate Offering Price** | **Fee Rate** | **Amount of<br>Registration Fee** |
| Equity | Common Stock, par value $0.00001 per share | Other | 2249863(2) | $8.99(3) | $20226268.37 | $0.0001102 | $2228.93 |
| Total Offering Amounts | Total Offering Amounts | Total Offering Amounts | Total Offering Amounts |  | $20226268.37 |  | $2228.93 |
| Total Fee Offsets | Total Fee Offsets | Total Fee Offsets | Total Fee Offsets |  |  |  |  |
| Net Fee Due | Net Fee Due | Net Fee Due | Net Fee Due |  |  |  | $2228.93 |

---

(1)Pursuant to Rule 416(a) under the Securities Act of 1933, as amended (the "Securities Act"), this Registration Statement will also cover any additional shares of the common stock of Evolus, Inc. (the "Company" or the "Registrant") that become issuable by reason of any stock dividend, stock split, recapitalization, or other similar transaction effected that results in an increase to the number of outstanding shares of the Registrant's common stock.

(2)Consists of shares issuable under the Evolus, Inc. 2017 Omnibus Incentive Plan (the "Plan").

(3)Estimated in accordance with Rules 457(c) and (h) solely for the purpose of calculating the registration fee on the basis of the average of the high and low prices of the Registrant's common stock as reported on the Nasdaq Global Market on March 2, 2023.

## Ex-5

**Exhibit 5**

[Evolus Letterhead]

March 8, 2023

Evolus, Inc.

520 Newport Center Drive, Suite 1200

Newport Beach, California 92660

Ladies and Gentlemen:

In connection with the registration of up to 2,249,863 shares of common stock of Evolus, Inc., a Delaware corporation (the "Company"), par value $0.00001 per share (the "Shares"), under the Securities Act of 1933, as amended, pursuant to a Registration Statement on Form S-8 (the "Registration Statement"), filed with the Securities and Exchange Commission on or about the date hereof, such Shares to be issued or delivered pursuant to the Evolus, Inc. 2017 Omnibus Incentive Plan (the "Plan"), you have requested my opinion set forth below.

In my capacity as counsel, I have examined originals or copies of those corporate and other records of the Company I considered appropriate.

On the basis of such examination and my consideration of those questions of law I considered relevant, and subject to the limitations and qualifications in this opinion, I am of the opinion that the Shares have been duly authorized by all necessary corporate action on the part of the Company and, when issued in accordance with such authorization, the provisions of the Plan and relevant agreements duly authorized by and in accordance with the terms of the Plan, and upon payment for and delivery of the Shares as contemplated in accordance with the Plan, and either (a) the countersigning of the certificate or certificates representing the Shares by a duly authorized signatory of the registrar for the Company's Common Stock, or (b) the book-entry of the Shares by the transfer agent for the Company's Common Stock in the name of The Depository Trust Company or its nominee, the Shares will be validly issued, fully paid and non-assessable.

I consent to your filing this opinion as an exhibit to the Registration Statement.

---

| |
|:---|
| Yours truly, |
| /s/ Jeffrey Plumer |
| Jeffrey Plumer |
| General Counsel |

---

## Exhibit 23.1

**Exhibit 23.1**

**Consent of Independent Registered Public Accounting Firm**

We consent to the incorporation by reference in the Registration Statement (Form S-8) pertaining to the Evolus, Inc. 2017 Omnibus Incentive Plan of our report dated March 8, 2023, with respect to the consolidated financial statements of Evolus, Inc. included in its Annual Report (Form 10-K) for the year ended December 31, 2022, filed with the Securities and Exchange Commission.

/s/ Ernst & Young LLP

Irvine, California

March 8, 2023

<br>